A bayesian population PK-PD model of ispinesib-induced myelosuppressionKATHMAN, S. J; WILLIAMS, D. H; HODGE, J. P et al.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 1, pp 88-94, issn 0009-9236, 7 p.Article

Conditioning the leukemic patient before allogeneic BMT : value of intensifying immunosuppression in the context of different levels of T lymphocyte depletion of the graftMIRALBELL, R; CHAPUIS, B; NOUET, P et al.Bone marrow transplantation (Basingstoke). 1993, Vol 11, Num 6, pp 447-451, issn 0268-3369Article

Chemotherapy-induced myelosuppressionMAXWELL, M. B; MAHER, K. E.Seminars in oncology nursing. 1992, Vol 8, Num 2, pp 113-123, issn 0749-2081Article

The use of ranitidine in bone marrow transplantation: a review of 223 casesAGURA, E. D; VILA, E; PETERSEN, F. B et al.Transplantation. 1988, Vol 46, Num 1, pp 53-56, issn 0041-1337Article

A mechanistic mathematical model of temozolomide myelosuppression in children with high-grade gliomasPANETTA, John Carl; KIRSTEIN, Mark N; GAJJAR, A. J et al.Mathematical biosciences. 2003, Vol 186, Num 1, pp 29-41, issn 0025-5564, 13 p.Article

Almost a tragedy: severe methotrexate toxicity in a hemodialysis patient treated for ectopic pregnancyWILLNER, Nadav; STORCH, Shimon; TADMOR, Tamar et al.European journal of clinical pharmacology. 2014, Vol 70, Num 3, pp 261-263, issn 0031-6970, 3 p.Article

5-androstenediol stimulates multilineage hematopoiesis in rhesus monkeys with radiation-induced myelosuppressionSTICKNEY, Dwight R; DOWDING, Charles; GARSD, Armando et al.International immunopharmacology. 2006, Vol 6, Num 11, pp 1706-1713, issn 1567-5769, 8 p.Article

Ex vivo activated immune cells promote survival and stimulate multilineage hematopoietic recovery in myelosuppressed miceGONG LI; XIAOHUAI WANG; LUBO WU et al.Journal of immunotherapy (1997). 2005, Vol 28, Num 4, pp 420-425, issn 1524-9557, 6 p.Article

Protective effects of glutathione on 5-fluorouracil-induced myelosuppression in miceKOJIMA, Seiji; TAKABA, Katsumi; KIMOTO, Naoya et al.Archives of toxicology. 2003, Vol 77, Num 5, pp 285-290, issn 0340-5761, 6 p.Article

A randomized cross-over trial to determine the effect of Cremophor EL on the pharmacodynamics and pharmacokinetics of carboplatin chemotherapyLOI, Sherene; RISCHIN, Danny; MICHAEL, Michael et al.Cancer chemotherapy and pharmacology. 2004, Vol 54, Num 5, pp 407-414, issn 0344-5704, 8 p.Article

Mistaken identity: misclassification of TPMT phenotype following blood transfusionCHEUNG, Seau-Tak; ALLAN, Robert N.European journal of gastroenterology & hepatology. 2003, Vol 15, Num 11, pp 1245-1247, issn 0954-691X, 3 p.Article

Results of decitabine (5-aza-2'deoxycytidine) therapy in 130 patients with chronic myelogenous leukemiaKANTARJIAN, Hagop M; O'BRIEN, Susan; KEATING, Michael et al.Cancer. 2003, Vol 98, Num 3, pp 522-528, issn 0008-543X, 7 p.Article

The presence of a significant association between elevated PRV-1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythaemiaJOHANSSON, Peter; ANDREASSON, Björn; SAFAI-KUTTI, Soodabeh et al.European journal of haematology. 2003, Vol 70, Num 6, pp 358-362, issn 0902-4441, 5 p.Article

Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioningPREBET, T; DEVILLIER, R; FURST, S et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 10, pp 1574-1575, issn 0268-3369, 2 p.Article

Le risque de neutropénieLa Revue du praticien (Paris). 2006, Vol 56, Num 18, pp 2042-2042, issn 0035-2640, 1 p.Article

Granulocyte colony-stimulating factor : effective in ameliorating fluorouracil-based myelosuppression ?CHRISTMAN, K; SALTZ, L; SCHWARTZ, G et al.Journal of the National Cancer Institute. 1993, Vol 85, Num 10, pp 826-827, issn 0027-8874Article

Current status of haploidentical stem cell transplantationDEY, Bimalangshu R; SPITZER, Thomas R.British journal of haematology. 2006, Vol 135, Num 4, pp 423-437, issn 0007-1048, 15 p.Article

Circumvention of chemotherapy-induced myelosuppression by transfer of the mdr1 geneBOESEN, J. J. B; NOOTER, K; VALERIO, D et al.Biotherapy (Dordrecht). 1993, Vol 6, Num 4, pp 291-302, issn 0921-299XArticle

Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemiaCLAXTON, D; DEISSEROTH, A; TALPAZ, M et al.Blood. 1992, Vol 79, Num 4, pp 997-1002, issn 0006-4971Article

Complications of intravesical chemotherapyBRANTLEY THRASHER, J; DAVID CRAWFORD, E.Urologic clinics of North America. 1992, Vol 19, Num 3, pp 529-539, issn 0094-0143Article

Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimenBERI, R; CHUNDURI, S; RONDELLI, D et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 2, pp 249-253, issn 0268-3369, 5 p.Article

The evolution of hematopoietic SCT in myelodysplastic syndromeKINDWALL-KELLER, T; ISOLA, L. M.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 8, pp 597-609, issn 0268-3369, 13 p.Article

Mechanism of flt3 ligand expression in bone marrow failure : Translocation from intracellular stores to the surface of T lymphocytes after chemotherapy-induced suppression of hematopoiesisCHKLOVSKAIA, E; JANSEN, W; NISSEN, C et al.Blood. 1999, Vol 93, Num 8, pp 2595-2604, issn 0006-4971Article

Effect of conagenin on thrombocytopenia induced by antitumor agents in miceKAWATSU, M; YAMASHITA, T; ISHIZUKA, M et al.Journal of antibiotics (Tokyo. 1968). 1994, Vol 47, Num 10, pp 1123-1129, issn 0021-8820Article

Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapyMEROPOL, N. J; MILLER, L. L; KORN, E. L et al.Journal of the National Cancer Institute. 1992, Vol 84, Num 15, pp 1201-1203, issn 0027-8874Article